Applied Therapeutics (APLT) Total Liabilities (2023 - 2025)
Historic Total Liabilities for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to $34.9 million.
- Applied Therapeutics' Total Liabilities fell 6529.89% to $34.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.9 million, marking a year-over-year decrease of 6529.89%. This contributed to the annual value of $29.7 million for FY2024, which is 5875.88% down from last year.
- Applied Therapeutics' Total Liabilities amounted to $34.9 million in Q3 2025, which was down 6529.89% from $19.9 million recorded in Q2 2025.
- In the past 5 years, Applied Therapeutics' Total Liabilities ranged from a high of $100.7 million in Q3 2024 and a low of $19.9 million during Q2 2025
- Its 3-year average for Total Liabilities is $50.5 million, with a median of $48.0 million in 2023.
- Per our database at Business Quant, Applied Therapeutics' Total Liabilities skyrocketed by 14633.17% in 2024 and then plummeted by 7588.87% in 2025.
- Applied Therapeutics' Total Liabilities (Quarter) stood at $72.0 million in 2023, then plummeted by 58.76% to $29.7 million in 2024, then grew by 17.69% to $34.9 million in 2025.
- Its Total Liabilities stands at $34.9 million for Q3 2025, versus $19.9 million for Q2 2025 and $20.2 million for Q1 2025.